Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Depreciation & Amortization (CF) (2020 - 2024)

RAPT Therapeutics' Depreciation & Amortization (CF) history spans 5 years, with the latest figure at $300000.0 for Q4 2024.

  • For Q4 2024, Depreciation & Amortization (CF) fell 2.28% year-over-year to $300000.0; the TTM value through Dec 2024 reached $1.2 million, down 2.52%, while the annual FY2024 figure was $1.2 million, 0.0% changed from the prior year.
  • Depreciation & Amortization (CF) for Q4 2024 was $300000.0 at RAPT Therapeutics, roughly flat from $300000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $396000.0 in Q2 2020 and bottomed at $196000.0 in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $299500.0 (2020), against an average of $276700.0.
  • The largest annual shift saw Depreciation & Amortization (CF) crashed 44.44% in 2021 before it surged 50.0% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $265000.0 in 2020, then fell by 26.04% to $196000.0 in 2021, then rose by 28.57% to $252000.0 in 2022, then increased by 21.83% to $307000.0 in 2023, then decreased by 2.28% to $300000.0 in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Depreciation & Amortization (CF) are $300000.0 (Q4 2024), $300000.0 (Q3 2024), and $300000.0 (Q2 2024).